when is retatrutide expected to be available vs Tirzepatide: 28.7% vs 22.5% (2026) Retatrutide Timeline: Week-by-Week Results (48

& Zen, K

The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]

Immunofluorescence staining of Ki67, a marker for proliferating cells, was used to assess the proliferation of human umbilical vein endothelial cells (HUVECs) 63

You may not be able to eat bigger meals on GLP-1, and that is okay

The meals in this plan are built to be gentle enough that most of them work on sensitive days, but give yourself permission to simplify even further when you need to

Second, the dysesthesia signal